Clorox Reports 18 Percent EPS Growth in Q2; Raises Fiscal Year 2016 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Clorox (CLX) Proves Conservative on Initial FY16 Guidance - UBS Raises PT to $110
February 5, 2016 9:49 AM ESTUBS reiterated a Sell rating on Clorox (NYSE: CLX), and raised the price target to $110.00 (from $105.00), following the company's 2Q earnings report. CLX reported $1.14 in EPS, beating consensus estimates of $1.05. This outperformance was driven largely by +210 bps in GM expansion. CLX did not raise FY16... More
Clorox (CLX) Tops Q2 EPS by 9c; Boosts Outlook Modestly
February 4, 2016 6:33 AM ESTClorox (NYSE: CLX) reported Q2 EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.35 billion.
GUIDANCE:
Clorox sees FY2016 EPS of $4.75-$4.90, versus prior guidance of $4.68-$4.83 and the... More



